CCN2 and diabetic kidney disease: Thus, podocyte-specific CTGF overexpression worsened diabetic nephropathy 222, whereas reducing CTGF expression by specific antisense oligonucleotides (ASO) improved kidney function and reduced the mesangial matrix expansion in mouse models of type 1 and 2 diabetes 221.